Ruan Sheng-Yuan, Chien Jung-Yien, Hsueh Po-Ren
Department of Internal Medicine, National Taiwan University Hospital Yun-Lin Branch, Taiwan.
Clin Infect Dis. 2009 Jul 1;49(1):e11-7. doi: 10.1086/599614.
During the past 2 decades, invasive trichosporonosis has emerged as an opportunistic infectious disease in immunocompromised patients. However, no case series have been reported recently.
All patients with a culture that was positive for Trichosporon species from May 2000 through May 2008 at a medical center were evaluated. The identity of all Trichosporon species was confirmed by analysis of the intergenic spacer 1 region of the fungal ribosomal RNA gene. In vitro susceptibility testing was performed using the reference broth microdilution method.
Forty-three patients were found to have a culture that was positive for Trichosporon species. T. asahii was the most frequently isolated species (32 isolates; 74%), followed by T. dermatis (5; 12%), T. montevideense (2; 5%), and T. asteroides (1; 2%), T. cutaneum (1; 2%), T. faecale (1; 2%), and T. ovoides (1; 2%). Nineteen patients had invasive infections; 16 (84%) were caused by T. asahii, and 1 (5%) each was caused by T. dermatis, T. montevideense, and T. asteroides. Of the 19 episodes of invasive trichosporonosis, 14 (74%) were fungemia, 3 (16%) were pulmonary infection, and 1 (5%) each was soft-tissue infection and meningitis. Most invasive infections were associated with prior antibiotic therapy (95%), use of a central catheter (90%), malignancy (58%), and intensive care unit admission (47%). Azoles had good in vitro activity, whereas amphotericin B and echinocandins were not active against Trichosporon isolates. The 30-day all-cause mortality rate was 42% and was higher among patients with a malignancy (55%) than among those without an underlying malignancy (25%).
Invasive trichosporonosis tended to develop in patients with an underlying malignancy and to be associated with higher mortality. T. asahii and other unusual Trichosporon species may cause invasive trichosporonosis.
在过去20年中,侵袭性毛孢子菌病已成为免疫功能低下患者的一种机会性传染病。然而,最近尚无病例系列报道。
对2000年5月至2008年5月在某医疗中心培养出毛孢子菌属阳性的所有患者进行评估。通过分析真菌核糖体RNA基因的基因间隔区1区域确认所有毛孢子菌属的种类。采用参考肉汤微量稀释法进行体外药敏试验。
发现43例患者培养出毛孢子菌属阳性。阿萨希毛孢子菌是最常分离出的菌种(32株;74%),其次是皮肤毛孢子菌(5株;12%)、蒙得维的亚毛孢子菌(2株;5%)、星状毛孢子菌(1株;2%)、皮毛发孢子菌(1株;2%)、粪便毛孢子菌(1株;2%)和卵形毛孢子菌(1株;2%)。19例患者发生侵袭性感染;16例(84%)由阿萨希毛孢子菌引起,1例(5%)由皮肤毛孢子菌、蒙得维的亚毛孢子菌和星状毛孢子菌各引起1例。在19例侵袭性毛孢子菌病发作中,14例(74%)为真菌血症,3例(16%)为肺部感染,1例(5%)为软组织感染和脑膜炎。大多数侵袭性感染与先前的抗生素治疗(95%)、中心静脉导管的使用(90%)、恶性肿瘤(58%)和入住重症监护病房(47%)有关。唑类药物具有良好的体外活性,而两性霉素B和棘白菌素对毛孢子菌分离株无活性。30天全因死亡率为42%,恶性肿瘤患者(55%)高于无潜在恶性肿瘤患者(25%)。
侵袭性毛孢子菌病倾向于在有潜在恶性肿瘤的患者中发生,且死亡率较高。阿萨希毛孢子菌和其他不常见的毛孢子菌属可能引起侵袭性毛孢子菌病。